Vaxart Analyst Ratings
Vaxart Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/19/2022 | 41.51% | B. Riley Securities | $6 → $1.5 | Maintains | Neutral |
| 09/02/2022 | 654.72% | Cantor Fitzgerald | $11 → $8 | Maintains | Overweight |
| 05/19/2022 | 466.04% | B. Riley Securities | $7 → $6 | Maintains | Neutral |
| 11/02/2021 | 1315.09% | Cantor Fitzgerald | → $15 | Initiates Coverage On | → Overweight |
| 06/30/2021 | 749.06% | B. Riley Securities | $13 → $9 | Downgrades | Buy → Neutral |
| 06/24/2021 | 1126.42% | Jefferies | → $13 | Initiates Coverage On | → Buy |
| 06/11/2021 | 1598.11% | Piper Sandler | → $18 | Initiates Coverage On | → Overweight |
| 08/12/2020 | 1503.77% | HC Wainwright & Co. | $7 → $17 | Maintains | Buy |
| 07/13/2020 | 1975.47% | B. Riley Securities | → $22 | Initiates Coverage On | → Buy |
| 04/30/2020 | 560.38% | HC Wainwright & Co. | $3 → $7 | Reiterates | → Buy |
| 06/27/2019 | 88.68% | HC Wainwright & Co. | → $2 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 12/19/2022 | 41.51% | B.莱利证券 | $6 → $1.5 | 维护 | 中性 |
| 09/02/2022 | 654.72% | 康托·菲茨杰拉德 | $11 → $8 | 维护 | 超重 |
| 05/19/2022 | 466.04% | B.莱利证券 | $7 → $6 | 维护 | 中性 |
| 11/02/2021 | 1315.09% | 康托·菲茨杰拉德 | → $15 | 开始承保 | →超重 |
| 06/30/2021 | 749.06% | B.莱利证券 | $13 → $9 | 评级下调 | 购买→中性 |
| 06/24/2021 | 1126.42% | 杰富瑞 | → $13 | 开始承保 | →购买 |
| 06/11/2021 | 1598.11% | 派珀·桑德勒 | → $18 | 开始承保 | →超重 |
| 08/12/2020 | 1503.77% | HC Wainwright公司 | $7 → $17 | 维护 | 买 |
| 07/13/2020 | 1975.47% | B.莱利证券 | → $22 | 开始承保 | →购买 |
| 04/30/2020 | 560.38% | HC Wainwright公司 | $3 → $7 | 重申 | →购买 |
| 06/27/2019 | 88.68% | HC Wainwright公司 | → $2 | 开始承保 | →购买 |
What is the target price for Vaxart (VXRT)?
Vaxart(VXRT)的目标价是多少？
The latest price target for Vaxart (NASDAQ: VXRT) was reported by B. Riley Securities on December 19, 2022. The analyst firm set a price target for $1.50 expecting VXRT to rise to within 12 months (a possible 41.51% upside). 3 analyst firms have reported ratings in the last year.
B·莱利证券于2022年12月19日报道了瓦克沙特(纳斯达克：VXRT)的最新目标价。这家分析公司将目标价定为1.50美元，预计VXRT将在12个月内上涨(可能上涨41.51%)。3家分析公司在过去一年公布了评级。
What is the most recent analyst rating for Vaxart (VXRT)?
Vaxart(VXRT)最近的分析师评级是多少？
The latest analyst rating for Vaxart (NASDAQ: VXRT) was provided by B. Riley Securities, and Vaxart maintained their neutral rating.
纳斯达克(Sequoia Capital：VXRT)的最新分析师评级由B.Riley Securities提供，Vaxart维持中性评级。
When is the next analyst rating going to be posted or updated for Vaxart (VXRT)?
Vaxart(VXRT)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vaxart, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vaxart was filed on December 19, 2022 so you should expect the next rating to be made available sometime around December 19, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括查看公开的财务报表，与Vaxart的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Vaxart的上一次评级是在2022年12月19日提交的，因此您应该预计下一次评级将在2023年12月19日左右提供。
Is the Analyst Rating Vaxart (VXRT) correct?
分析师评级Vaxart(VXRT)正确吗？
While ratings are subjective and will change, the latest Vaxart (VXRT) rating was a maintained with a price target of $6.00 to $1.50. The current price Vaxart (VXRT) is trading at is $1.06, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Vaxart(VXRT)评级维持不变，目标价在6.00美元至1.50美元之间。Vaxart(VXRT)目前的交易价格为1.06美元，超出了分析师的预测区间。